Aarkstore Enterprise---helix Biopharma Corp. (hbp) - Financial And Strategic Analysis Review

Share:    

Helix BioPharma Corp. (Helix) is a biopharmaceutical company engaged in developing innovative products for the prevention and treatment of cancer. The company is concentrating on the development of two clinical stage drugs with precise cancer applications; L-DOS47 for lung adenocarcinoma and Topical Interferon Alpha-2b for low-grade squamous intraepithelial cervical lesions and ano-genital warts. The company distributes drug products in Canada through its subsidiary Rivex Pharma Inc. Helix is headquartered in Ontario, Canada

Helix BioPharma Corp. Key Recent Developments

Mar 22, 2010: Helix BioPharma Completes Phase II Trial Of Topical Interferon Alpha-2b

Mar 10, 2010: Helix Reports Revenues Of CAD1.12 Million In Q2 Fiscal 2010

Feb 12, 2010: Helix BioPharma Reports Interferon Alpha-2b Study Results

Dec 09, 2009: Helix Reports Revenues Of CAD1.02 Million In Q1 Fiscal 2010

Nov 05, 2009: Helix BioPharma Completes Patient Enrollment In Phase II Trial Of Topical Interferon Alpha-2b

This comprehensive SWOT analysis of Helix BioPharma Corp. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

For more information please contact :

http://www.aarkstore.com/reports/Helix-BioPharma-Corp-HBP-Financial-and-Strategic-Analysis-Review-62743.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---optos Plc (opts) - Financial And Strategic Analysis Review Aarkstore Enterprise---aerocrine Ab (aero B) - Financial And Strategic Analysis Review Aarkstore Enterprise---ablynx (ablx) - Financial And Strategic Analysis Review Aarkstore Enterprise---viking Systems, Inc. (vksy.ob) - Financial And Strategic Analysis Review Aarkstore Enterprise---labtech Systems Limited (lbt) - Financial And Strategic Analysis Review Aarkstore Enterprise---tieto Corporation (tie1v) - Financial And Strategic Analysis Review Aarkstore Enterprise---sdi Limited (sdi) - Financial And Strategic Analysis Review Aarkstore Enterprise---iris International, Inc. (iris) - Financial And Strategic Analysis Review Aarkstore Enterprise---meridian Bioscience, Inc. (vivo) - Financial And Strategic Analysis Review Aarkstore Enterprise---radnet, Inc. (rdnt) - Financial And Strategic Analysis Review Exchange Rates And Trading How Fap Turbo Can Transform Your Trading Success About How To Read Trading Graphs